N/A
Completed N=105
Cognitive Adaptive Training for Improving Medication Adherence, Symptoms, and Function in People With Schizophrenia
Source: ClinicalTrials.gov NCT00455663 ↗Enrolled (actual)
105
Serious AEs
0.0%
Results posted
Jun 2015
Primary outcomePrimary: Medication Adherence-pill Count — 80.8; 81.43; 57.3 percentage of medication taken
Summary
This study will compare the effectiveness of three treatments in improving medication adherence, symptoms, and function in people with schizophrenia.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Medication Adherence-pill Count |
80.8; 81.43; 57.3 | — |
| PRIMARY Positive Symptoms |
2.3; 2.5; 2.3 | — |
| PRIMARY Social and Occupational Functioning Scale Score |
50.8; 45.2; 42.6 | — |
| PRIMARY Number of Patients Surviving Without Relapse/Exacerbation |
15; 14; 4 | — |
Eligibility Criteria
Inclusion Criteria
- Diagnosis of schizophrenia or schizoaffective disorder
- If entering the study as an inpatient, hospitalization was recent
- Currently receiving treatment with an atypical antipsychotic and continuation on the medication has been recommended
- Assumes primary responsibility for taking medication
- Currently living in a stable environment
Exclusion Criteria
- History of significant head trauma, seizure disorder, or mental retardation
- History of alcohol or drug abuse or dependence within 1 month prior to study entry
- History of violence within 6 months prior to study entry
Data sourced from ClinicalTrials.gov (NCT00455663). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.